Salarius Pharmaceuticals, Inc.
SEC CIK 1615219 · SLRX · last insider filing 2026-01-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hanish Arnold C | Director | filed 2019 - 2026 |
| Arthur David J. | Director · Chief Executive Officer | filed 2019 - 2024 |
| Lieber Jonathan I | Director | filed 2020 - 2024 |
| Lammers Paul | Director | filed 2019 - 2024 |
| Mcvicar William K. | Director · President, R&D | filed 2017 - 2024 |
| Burleson Tess | Director | filed 2019 - 2024 |
| Mccreedy Bruce J Jr. | Director | filed 2019 - 2024 |
| Northrup Jonathan P | Director | filed 2019 - 2020 |
| Westphal Christoph H | Director · President and CEO | filed 2015 - 2018 |
| Hutt Peter Barton | Director | filed 2015 - 2018 |
| Kozin Marc D | Director | filed 2015 - 2018 |
| Randle Stuart A | Director | filed 2015 - 2018 |
| Stacy Michelle | Director | filed 2016 - 2018 |
| Tung Roger D | Director | filed 2017 - 2018 |
| Capello Jeffrey D | Director | filed 2015 - 2017 |
| Perez Robert J | Director | filed 2015 - 2017 |
| Mackinnon Roderick | Director | filed 2015 - 2017 |
| Sculley John | Director | filed 2015 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Pierce Frederick II | Chief Executive Office | filed 2025 - 2025 |
| Hibner Barbara Louise | Chief Scientific Officer | filed 2025 - 2025 |
| Marschel Peter Klaus | Chief Business Officer | filed 2025 - 2025 |
| Rosenblum Mark J | Exec VP Finance, Interim CFO | filed 2019 - 2025 |
| Jordan Scott | Chief Financial Officer | filed 2019 - 2020 |
| Chuang Pao-Yu | Controller | filed 2019 - 2019 |
| Mccabe John P. | VP of Finance & Treasurer | filed 2015 - 2018 |
| Wessel Thomas | Chief Medical Officer | filed 2015 - 2018 |
| Woo Elizabeth | VP, Investor Relations | filed 2015 - 2018 |
| Hadfield Robert | General Counsel & Secretary | filed 2015 - 2017 |
| Lindemann Katharine | Chief Operating Officer | filed 2015 - 2017 |
| Hahn Marina | President, Consumer Goods | filed 2015 - 2015 |
| Cermak Jennifer | VP Program Management | filed 2015 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.